tirzepatide when you stop What happens when you stop your weight loss medication? For years, obesity GLP-1s and TTC: When to

Again, testing helps to identify abnormal levels of neurotransmitters and hormones

While this treatment offers transformative benefits, certain medical conditions may disqualify individuals from undergoing this treatment

Vitiligo is epidemiologically connected with diabetes type I and type II suggesting that both autoimmune and non-autoimmune components are involved in the pathogenesis ( Despite different strategies are currently available, the management of vitiligo remains challenging

Pathogenic variants in the penultimate exon of FBN1 have been reported to be associated with a distinct phenotype of generalized lipodystrophy that share some clinical features with neonatal progeroid syndrome (WiedemannRautenstrauch syndrome), a very severe disorder with only a few patients described who could reach their late childhood (150-152)